Meta-analysis and pharmacoeconomic study of rasagiline versus selegiline in the treatment of Parkinson’s disease
Abstract Objective Given the persistent absence of direct head-to-head trials, this study aimed to evaluate the comparative efficacy, safety, and cost-effectiveness of rasagiline versus selegiline as early-stage monotherapy for Parkinson’s disease (PD), informing clinical selection and healthcare policies in China. Met...